These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6791550)

  • 1. Heparin binding and protease inhibitor activity of chemically modified antithrombin III.
    Blackburn MN; Smith RL; Sibley CC; Johnson VA
    Ann N Y Acad Sci; 1981; 370():700-7. PubMed ID: 6791550
    [No Abstract]   [Full Text] [Related]  

  • 2. The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence.
    Blackburn MN; Smith RL; Carson J; Sibley CC
    J Biol Chem; 1984 Jan; 259(2):939-41. PubMed ID: 6693405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of tryptophan modification upon digestion of antithrombin III by elastase.
    Scully MF; Shah N; Ellis V; Kakkar VV
    Thromb Haemost; 1991 Apr; 65(4):351-4. PubMed ID: 2057915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The heparin binding site of antithrombin III. Evidence for a critical tryptophan residue.
    Blackburn MN; Sibley CC
    J Biol Chem; 1980 Feb; 255(3):824-6. PubMed ID: 7356660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of chemical modification of tryptophan residues on the properties of human antithrombin III.
    Shah N; Scully MF; Ellis V; Kakkar VV
    Thromb Res; 1990 Feb; 57(3):343-52. PubMed ID: 2315891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of tryptophan residues in heparin-antithrombin interactions.
    Karp GI; Marcum JA; Rosenberg RD
    Arch Biochem Biophys; 1984 Sep; 233(2):712-20. PubMed ID: 6486808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin conformation and the catalytic role of heparin. II. Is the heparin-induced conformational change in antithrombin required for rapid inactivation of thrombin?
    Peterson CB; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7559-66. PubMed ID: 3584127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of heparin to human antithrombin III as studied by measurements of tryptophan fluorescence.
    Einarsson R; Andersson LO
    Biochim Biophys Acta; 1977 Jan; 490(1):104-11. PubMed ID: 65182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavior of antithrombin III isoforms on immobilized heparins. Evidence that the isoforms bind to different numbers of low-affinity heparin sites.
    Carlson TH; Babcock T; Atencio AC; Levinson C; Mora HR
    J Biol Chem; 1988 Feb; 263(5):2187-94. PubMed ID: 3339006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.
    Barrowcliffe TW
    Thromb Haemost; 1980 Feb; 42(5):1434-45. PubMed ID: 7368150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridoxylation of essential lysines in the heparin-binding site of antithrombin III.
    Pecon JM; Blackburn MN
    J Biol Chem; 1984 Jan; 259(2):935-8. PubMed ID: 6420409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invalidation of concerns with long-term use of heparin: thrombin/antithrombin III interactions.
    Goosen MF; Sefton MV
    Trans Am Soc Artif Intern Organs; 1982; 28():451-5. PubMed ID: 7164279
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin III, a serpin family protease inhibitor, is a major heparin binding protein in porcine aqueous humor.
    Rao PV; Allingham RR; Herndon LW; Epstein DL
    Biochem Biophys Res Commun; 2000 May; 272(1):1-5. PubMed ID: 10872794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the antithrombin-binding site in heparin.
    Lindahl U; Bäckström G; Höök M; Thunberg L; Fransson LA; Linker A
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3198-202. PubMed ID: 226960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the kinetic behavior of human and bovine proteins in the heparin-catalyzed antithrombin III/thrombin reaction.
    Cunningham MT; Nelsestuen GL
    Biochim Biophys Acta; 1987 Jan; 911(1):66-70. PubMed ID: 3790599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III.
    Watton J; Longstaff C; Lane DA; Barrowcliffe TW
    Biochemistry; 1993 Jul; 32(28):7286-93. PubMed ID: 8343518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of an affinity chromatography gel for AT III. Effect of purification of AT III-binding sequence of heparin.
    Tomono T; Igarashi S; Sawada E
    Thromb Res; 1984 Aug; 35(4):467-73. PubMed ID: 6484894
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetic analysis of various heparin fractions and heparin substitutes in the thrombin inhibition reaction.
    Pletcher CH; Cunningham M; Nelsestuen GL
    Biochim Biophys Acta; 1985 Jan; 838(1):106-13. PubMed ID: 2578296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.